Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Gains from Investment Securities: 2012-2025

Historic Gains from Investment Securities for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to -$100,000.

  • Ptc Therapeutics' Gains from Investment Securities fell 101.50% to -$100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $43.9 million, marking a year-over-year increase of 335.05%. This contributed to the annual value of $17.6 million for FY2024, which is 113.74% up from last year.
  • Per Ptc Therapeutics' latest filing, its Gains from Investment Securities stood at -$100,000 for Q3 2025, which was down 100.28% from $36.1 million recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Gains from Investment Securities high stood at $80.3 million for Q2 2022, and its period low was -$128.9 million during Q2 2023.
  • Its 3-year average for Gains from Investment Securities is -$6.5 million, with a median of $2.4 million in 2023.
  • As far as peak fluctuations go, Ptc Therapeutics' Gains from Investment Securities plummeted by 2,627.27% in 2021, and later surged by 2,235.52% in 2022.
  • Quarterly analysis of 5 years shows Ptc Therapeutics' Gains from Investment Securities stood at -$3.9 million in 2021, then skyrocketed by 113.44% to $523,000 in 2022, then tumbled by 616.25% to -$2.7 million in 2023, then surged by 276.63% to $4.8 million in 2024, then crashed by 101.50% to -$100,000 in 2025.
  • Its Gains from Investment Securities was -$100,000 in Q3 2025, compared to $36.1 million in Q2 2025 and $3.0 million in Q1 2025.